Heart Disease

Bloomer Tech Receives $1.9M from the NIH for a Clinical Study in Women’s Heart Health

Bloomer Tech, a healthcare technology company based in Boston, has been granted $1.9 million by the National Heart, Lung, and Blood Institute for a clinical study aimed at improving women’s cardiovascular health. This funding will support a randomized clinical trial for Bloomer Tech’s Tech-Augmented Garment (TAG), which integrates patented textile-based sensor technology to gather medical-grade data from women’s physiology. The award represents…

How Hello Heart Is Combating Heart Health Inequities with Digital Therapeutics

In heart disease, there are disparities in prevalence, mortality rate, and care across different groups. Women’s mortality rate for heart attacks is 2x higher than men – making heart disease their biggest health outcomes gap. Hypertension is a condition that disproportionately impacts Black adults – and the group experiences 30% more heart disease deaths compared to non-Hispanic White adults. Additionally, 25 million Spanish speakers receive about a third…

Swiss Femtech Startup CorDiFio Is Building an AI-powered Platform to Improve Heart Disease Diagnostics

Although 80% of cardiovascular diseases including stroke are preventable, heart diseases are the #1 cause of death in women today. Shockingly enough, however, around 50% of women, who have had a heart attack, get misdiagnosed with stress or anxiety. “We are a half-century behind in our knowledge about optimal screening, diagnosis, and treatment of heart disease in women. Every day, women pay…